These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2454 related articles for article (PubMed ID: 17992123)
1. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123 [TBL] [Abstract][Full Text] [Related]
2. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma]. Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477 [TBL] [Abstract][Full Text] [Related]
3. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary? Nahabedian MY; Tufaro AP; Manson PN Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009 [TBL] [Abstract][Full Text] [Related]
6. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. Keijzer R; Bril H; van der Loo EM; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391 [TBL] [Abstract][Full Text] [Related]
7. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
8. Sentinel node identification by scintigraphic methods in cutaneous melanoma. Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749 [TBL] [Abstract][Full Text] [Related]
9. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144 [TBL] [Abstract][Full Text] [Related]
10. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided? Schlag PM Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128 [TBL] [Abstract][Full Text] [Related]
11. Vulvar melanoma: is there a role for sentinel lymph node biopsy? de Hullu JA; Hollema H; Hoekstra HJ; Piers DA; Mourits MJ; Aalders JG; van der Zee AG Cancer; 2002 Jan; 94(2):486-91. PubMed ID: 11905414 [TBL] [Abstract][Full Text] [Related]
12. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?]. Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study. Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434 [TBL] [Abstract][Full Text] [Related]
14. [Prognosis of malignant melanoma following dissection regional lymph node metastases]. Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406 [TBL] [Abstract][Full Text] [Related]
15. The natural course of cutaneous melanoma. Leiter U; Meier F; Schittek B; Garbe C J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923 [TBL] [Abstract][Full Text] [Related]
16. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. Zapas JL; Coley HC; Beam SL; Brown SD; Jablonski KA; Elias EG J Am Coll Surg; 2003 Sep; 197(3):403-7. PubMed ID: 12946795 [TBL] [Abstract][Full Text] [Related]
17. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. McHugh JB; Su L; Griffith KA; Schwartz JL; Wong SL; Cimmino V; Chang AE; Johnson TM; Sabel MS Ann Surg Oncol; 2006 Sep; 13(9):1216-23. PubMed ID: 16952026 [TBL] [Abstract][Full Text] [Related]
18. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related]
19. Tumor lymphangiogenesis and melanoma metastasis. Rinderknecht M; Detmar M J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261 [TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas. Gutzmer R; Satzger I; Thoms KM; Völker B; Mitteldorf C; Kapp A; Bertsch HP; Kretschmer L J Dtsch Dermatol Ges; 2008 Mar; 6(3):198-203. PubMed ID: 18093216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]